Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Newly made nicotinamide compounds could potentially treat cancer.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

New patents include innovations in skin and hair care, disease treatment, plant stress tolerance, and protein purification.

Drug companies were interested in advertising directly to consumers to make back their money, but most didn't think it would help and were concerned about negative effects.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Jasmonic acid and its derivatives play important roles in plant health and have potential uses in medicine and agriculture.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Stopping finasteride and closing PFO can help prevent strokes in young adults.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Nanoemulgel is a promising method for applying topical drugs effectively, but safety must be evaluated due to new administration techniques.

Dosage regime inventions can be patentable in China, but legal uncertainty exists.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

Future work on macrolide antibiotic analysis will aim to enhance selectivity, sensitivity, and efficiency using advanced chromatographic methods.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Coffee and its by-products are promising for skin health benefits in cosmetics and help reduce environmental impact.